Capital Flow Monitor · Sponsors · CIK 1641404
Peca Labs, Inc.
4424 PENN AVENUE, SUITE 201, PITTSBURGH, PA, 15224 · 412-482-3755
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$21.5M
Sold
$12.8M
% sold
59.5%
Investors
30
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | D ·current | 506(b) | $21.5M | $12.8M | 59.5% | 30 | EDGAR ↗ |
| 2025-11-20 | D | 506(b) | $5.0M | $2.7M | 53.0% | 18 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- C. Douglas Bernstein — Executive Officer / Director, Pittsburgh, PA
-
Bob Donohue — Director, Pittsburgh, PA
1 other raise
- Lungpacer Medical, Inc. $16.0M of $20.0M · 80.0%
- Jon Kuhn — Director, Pittsburgh, PA
- Barbara Carryer — Director, Pittsburgh, PA
- Arush Kalra — Executive Officer, Pittsburgh, PA
- Samuel Navarro — Director, Pittsburgh, PA
- Joseph Bavaria — Director, Pittsburgh, PA
- Jeff O'Donnell — Director, Pittsburgh, PA
- Jamie Quinterno — Executive Officer, Pittsburgh, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.